Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
For study participants treated with tirzepatide (5 mg, 10 mg and 15 mg, respectively), nausea (11.9 percent, 15.9 percent, 22.2 percent), diarrhea (12.2 percent, 19.5 percent, 20.4 percent) and vomiting (4.9 percent, 8.2 percent, 8.3 percent) were more frequently experienced compared to insulin glargine (1.6 percent [nausea], 3.2 percent [diarrhea], 1.1 percent [vomiting])
Factors such as your overall health, existing medical conditions, and current treatments will be considered
Treatment in Comfort Receive professional healthcare in the comfort of your own home
Its biologically active
US$ 20.95
US$ 21.86
US$ 24.92
US$ 20.79
US$ 27.97
US$ 20.97
US$ 21.05
US$ 24.35
